The high failure rate of biologic resurfacing of the glenoid in young patients with glenohumeral arthritis
The current study evaluated the outcomes of biologic resurfacing of the glenoid using a lateral meniscus allograft or human acellular dermal tissue matrix at intermediate-term follow-up.
Autor*in: |
Strauss, Eric J. [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2014 |
---|
Schlagwörter: |
---|
Umfang: |
11 |
---|
Übergeordnetes Werk: |
Enthalten in: Tu1421 Complications of Botulinum Toxin Injections for Treatment of Esophageal Motility Disorders - van Hoeij, Froukje B. ELSEVIER, 2015, St. Louis, Mo |
---|---|
Übergeordnetes Werk: |
volume:23 ; year:2014 ; number:3 ; pages:409-419 ; extent:11 |
Links: |
---|
DOI / URN: |
10.1016/j.jse.2013.06.001 |
---|
Katalog-ID: |
ELV02831283X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV02831283X | ||
003 | DE-627 | ||
005 | 20230623193151.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jse.2013.06.001 |2 doi | |
028 | 5 | 2 | |a GBVA2014017000010.pica |
035 | |a (DE-627)ELV02831283X | ||
035 | |a (ELSEVIER)S1058-2746(13)00278-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 610 |q VZ |
082 | 0 | 4 | |a 570 |q VZ |
084 | |a BIODIV |q DE-30 |2 fid | ||
084 | |a 35.70 |2 bkl | ||
084 | |a 42.12 |2 bkl | ||
084 | |a 42.15 |2 bkl | ||
100 | 1 | |a Strauss, Eric J. |e verfasserin |4 aut | |
245 | 1 | 4 | |a The high failure rate of biologic resurfacing of the glenoid in young patients with glenohumeral arthritis |
264 | 1 | |c 2014 | |
300 | |a 11 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a The current study evaluated the outcomes of biologic resurfacing of the glenoid using a lateral meniscus allograft or human acellular dermal tissue matrix at intermediate-term follow-up. | ||
650 | 7 | |a Treatment Study |2 Elsevier | |
650 | 7 | |a Level IV |2 Elsevier | |
650 | 7 | |a Case Series |2 Elsevier | |
700 | 1 | |a Verma, Nikhil N. |4 oth | |
700 | 1 | |a Salata, Michael J. |4 oth | |
700 | 1 | |a McGill, Kevin C. |4 oth | |
700 | 1 | |a Klifto, Christopher |4 oth | |
700 | 1 | |a Nicholson, Gregory P. |4 oth | |
700 | 1 | |a Cole, Brian J. |4 oth | |
700 | 1 | |a Romeo, Anthony A. |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Mosby |a van Hoeij, Froukje B. ELSEVIER |t Tu1421 Complications of Botulinum Toxin Injections for Treatment of Esophageal Motility Disorders |d 2015 |g St. Louis, Mo |w (DE-627)ELV013436635 |
773 | 1 | 8 | |g volume:23 |g year:2014 |g number:3 |g pages:409-419 |g extent:11 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.jse.2013.06.001 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a FID-BIODIV | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_26 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_65 | ||
936 | b | k | |a 35.70 |j Biochemie: Allgemeines |q VZ |
936 | b | k | |a 42.12 |j Biophysik |q VZ |
936 | b | k | |a 42.15 |j Zellbiologie |q VZ |
951 | |a AR | ||
952 | |d 23 |j 2014 |e 3 |h 409-419 |g 11 | ||
953 | |2 045F |a 610 |
author_variant |
e j s ej ejs |
---|---|
matchkey_str |
straussericjvermanikhilnsalatamichaeljmc:2014----:hhgfiueaefilgceufcnotelniiyugains |
hierarchy_sort_str |
2014 |
bklnumber |
35.70 42.12 42.15 |
publishDate |
2014 |
allfields |
10.1016/j.jse.2013.06.001 doi GBVA2014017000010.pica (DE-627)ELV02831283X (ELSEVIER)S1058-2746(13)00278-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Strauss, Eric J. verfasserin aut The high failure rate of biologic resurfacing of the glenoid in young patients with glenohumeral arthritis 2014 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The current study evaluated the outcomes of biologic resurfacing of the glenoid using a lateral meniscus allograft or human acellular dermal tissue matrix at intermediate-term follow-up. Treatment Study Elsevier Level IV Elsevier Case Series Elsevier Verma, Nikhil N. oth Salata, Michael J. oth McGill, Kevin C. oth Klifto, Christopher oth Nicholson, Gregory P. oth Cole, Brian J. oth Romeo, Anthony A. oth Enthalten in Mosby van Hoeij, Froukje B. ELSEVIER Tu1421 Complications of Botulinum Toxin Injections for Treatment of Esophageal Motility Disorders 2015 St. Louis, Mo (DE-627)ELV013436635 volume:23 year:2014 number:3 pages:409-419 extent:11 https://doi.org/10.1016/j.jse.2013.06.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA GBV_ILN_26 GBV_ILN_40 GBV_ILN_65 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 23 2014 3 409-419 11 045F 610 |
spelling |
10.1016/j.jse.2013.06.001 doi GBVA2014017000010.pica (DE-627)ELV02831283X (ELSEVIER)S1058-2746(13)00278-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Strauss, Eric J. verfasserin aut The high failure rate of biologic resurfacing of the glenoid in young patients with glenohumeral arthritis 2014 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The current study evaluated the outcomes of biologic resurfacing of the glenoid using a lateral meniscus allograft or human acellular dermal tissue matrix at intermediate-term follow-up. Treatment Study Elsevier Level IV Elsevier Case Series Elsevier Verma, Nikhil N. oth Salata, Michael J. oth McGill, Kevin C. oth Klifto, Christopher oth Nicholson, Gregory P. oth Cole, Brian J. oth Romeo, Anthony A. oth Enthalten in Mosby van Hoeij, Froukje B. ELSEVIER Tu1421 Complications of Botulinum Toxin Injections for Treatment of Esophageal Motility Disorders 2015 St. Louis, Mo (DE-627)ELV013436635 volume:23 year:2014 number:3 pages:409-419 extent:11 https://doi.org/10.1016/j.jse.2013.06.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA GBV_ILN_26 GBV_ILN_40 GBV_ILN_65 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 23 2014 3 409-419 11 045F 610 |
allfields_unstemmed |
10.1016/j.jse.2013.06.001 doi GBVA2014017000010.pica (DE-627)ELV02831283X (ELSEVIER)S1058-2746(13)00278-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Strauss, Eric J. verfasserin aut The high failure rate of biologic resurfacing of the glenoid in young patients with glenohumeral arthritis 2014 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The current study evaluated the outcomes of biologic resurfacing of the glenoid using a lateral meniscus allograft or human acellular dermal tissue matrix at intermediate-term follow-up. Treatment Study Elsevier Level IV Elsevier Case Series Elsevier Verma, Nikhil N. oth Salata, Michael J. oth McGill, Kevin C. oth Klifto, Christopher oth Nicholson, Gregory P. oth Cole, Brian J. oth Romeo, Anthony A. oth Enthalten in Mosby van Hoeij, Froukje B. ELSEVIER Tu1421 Complications of Botulinum Toxin Injections for Treatment of Esophageal Motility Disorders 2015 St. Louis, Mo (DE-627)ELV013436635 volume:23 year:2014 number:3 pages:409-419 extent:11 https://doi.org/10.1016/j.jse.2013.06.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA GBV_ILN_26 GBV_ILN_40 GBV_ILN_65 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 23 2014 3 409-419 11 045F 610 |
allfieldsGer |
10.1016/j.jse.2013.06.001 doi GBVA2014017000010.pica (DE-627)ELV02831283X (ELSEVIER)S1058-2746(13)00278-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Strauss, Eric J. verfasserin aut The high failure rate of biologic resurfacing of the glenoid in young patients with glenohumeral arthritis 2014 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The current study evaluated the outcomes of biologic resurfacing of the glenoid using a lateral meniscus allograft or human acellular dermal tissue matrix at intermediate-term follow-up. Treatment Study Elsevier Level IV Elsevier Case Series Elsevier Verma, Nikhil N. oth Salata, Michael J. oth McGill, Kevin C. oth Klifto, Christopher oth Nicholson, Gregory P. oth Cole, Brian J. oth Romeo, Anthony A. oth Enthalten in Mosby van Hoeij, Froukje B. ELSEVIER Tu1421 Complications of Botulinum Toxin Injections for Treatment of Esophageal Motility Disorders 2015 St. Louis, Mo (DE-627)ELV013436635 volume:23 year:2014 number:3 pages:409-419 extent:11 https://doi.org/10.1016/j.jse.2013.06.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA GBV_ILN_26 GBV_ILN_40 GBV_ILN_65 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 23 2014 3 409-419 11 045F 610 |
allfieldsSound |
10.1016/j.jse.2013.06.001 doi GBVA2014017000010.pica (DE-627)ELV02831283X (ELSEVIER)S1058-2746(13)00278-4 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl Strauss, Eric J. verfasserin aut The high failure rate of biologic resurfacing of the glenoid in young patients with glenohumeral arthritis 2014 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The current study evaluated the outcomes of biologic resurfacing of the glenoid using a lateral meniscus allograft or human acellular dermal tissue matrix at intermediate-term follow-up. Treatment Study Elsevier Level IV Elsevier Case Series Elsevier Verma, Nikhil N. oth Salata, Michael J. oth McGill, Kevin C. oth Klifto, Christopher oth Nicholson, Gregory P. oth Cole, Brian J. oth Romeo, Anthony A. oth Enthalten in Mosby van Hoeij, Froukje B. ELSEVIER Tu1421 Complications of Botulinum Toxin Injections for Treatment of Esophageal Motility Disorders 2015 St. Louis, Mo (DE-627)ELV013436635 volume:23 year:2014 number:3 pages:409-419 extent:11 https://doi.org/10.1016/j.jse.2013.06.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA GBV_ILN_26 GBV_ILN_40 GBV_ILN_65 35.70 Biochemie: Allgemeines VZ 42.12 Biophysik VZ 42.15 Zellbiologie VZ AR 23 2014 3 409-419 11 045F 610 |
language |
English |
source |
Enthalten in Tu1421 Complications of Botulinum Toxin Injections for Treatment of Esophageal Motility Disorders St. Louis, Mo volume:23 year:2014 number:3 pages:409-419 extent:11 |
sourceStr |
Enthalten in Tu1421 Complications of Botulinum Toxin Injections for Treatment of Esophageal Motility Disorders St. Louis, Mo volume:23 year:2014 number:3 pages:409-419 extent:11 |
format_phy_str_mv |
Article |
bklname |
Biochemie: Allgemeines Biophysik Zellbiologie |
institution |
findex.gbv.de |
topic_facet |
Treatment Study Level IV Case Series |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Tu1421 Complications of Botulinum Toxin Injections for Treatment of Esophageal Motility Disorders |
authorswithroles_txt_mv |
Strauss, Eric J. @@aut@@ Verma, Nikhil N. @@oth@@ Salata, Michael J. @@oth@@ McGill, Kevin C. @@oth@@ Klifto, Christopher @@oth@@ Nicholson, Gregory P. @@oth@@ Cole, Brian J. @@oth@@ Romeo, Anthony A. @@oth@@ |
publishDateDaySort_date |
2014-01-01T00:00:00Z |
hierarchy_top_id |
ELV013436635 |
dewey-sort |
3610 |
id |
ELV02831283X |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV02831283X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623193151.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jse.2013.06.001</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014017000010.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV02831283X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1058-2746(13)00278-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.70</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.15</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Strauss, Eric J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The high failure rate of biologic resurfacing of the glenoid in young patients with glenohumeral arthritis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">11</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The current study evaluated the outcomes of biologic resurfacing of the glenoid using a lateral meniscus allograft or human acellular dermal tissue matrix at intermediate-term follow-up.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Treatment Study</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Level IV</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Case Series</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Verma, Nikhil N.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Salata, Michael J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McGill, Kevin C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Klifto, Christopher</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nicholson, Gregory P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cole, Brian J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Romeo, Anthony A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Mosby</subfield><subfield code="a">van Hoeij, Froukje B. ELSEVIER</subfield><subfield code="t">Tu1421 Complications of Botulinum Toxin Injections for Treatment of Esophageal Motility Disorders</subfield><subfield code="d">2015</subfield><subfield code="g">St. Louis, Mo</subfield><subfield code="w">(DE-627)ELV013436635</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:23</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:409-419</subfield><subfield code="g">extent:11</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jse.2013.06.001</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_26</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.70</subfield><subfield code="j">Biochemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.12</subfield><subfield code="j">Biophysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.15</subfield><subfield code="j">Zellbiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">23</subfield><subfield code="j">2014</subfield><subfield code="e">3</subfield><subfield code="h">409-419</subfield><subfield code="g">11</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Strauss, Eric J. |
spellingShingle |
Strauss, Eric J. ddc 610 ddc 570 fid BIODIV bkl 35.70 bkl 42.12 bkl 42.15 Elsevier Treatment Study Elsevier Level IV Elsevier Case Series The high failure rate of biologic resurfacing of the glenoid in young patients with glenohumeral arthritis |
authorStr |
Strauss, Eric J. |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV013436635 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health 570 - Life sciences; biology |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 610 VZ 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl The high failure rate of biologic resurfacing of the glenoid in young patients with glenohumeral arthritis Treatment Study Elsevier Level IV Elsevier Case Series Elsevier |
topic |
ddc 610 ddc 570 fid BIODIV bkl 35.70 bkl 42.12 bkl 42.15 Elsevier Treatment Study Elsevier Level IV Elsevier Case Series |
topic_unstemmed |
ddc 610 ddc 570 fid BIODIV bkl 35.70 bkl 42.12 bkl 42.15 Elsevier Treatment Study Elsevier Level IV Elsevier Case Series |
topic_browse |
ddc 610 ddc 570 fid BIODIV bkl 35.70 bkl 42.12 bkl 42.15 Elsevier Treatment Study Elsevier Level IV Elsevier Case Series |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
n n v nn nnv m j s mj mjs k c m kc kcm c k ck g p n gp gpn b j c bj bjc a a r aa aar |
hierarchy_parent_title |
Tu1421 Complications of Botulinum Toxin Injections for Treatment of Esophageal Motility Disorders |
hierarchy_parent_id |
ELV013436635 |
dewey-tens |
610 - Medicine & health 570 - Life sciences; biology |
hierarchy_top_title |
Tu1421 Complications of Botulinum Toxin Injections for Treatment of Esophageal Motility Disorders |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV013436635 |
title |
The high failure rate of biologic resurfacing of the glenoid in young patients with glenohumeral arthritis |
ctrlnum |
(DE-627)ELV02831283X (ELSEVIER)S1058-2746(13)00278-4 |
title_full |
The high failure rate of biologic resurfacing of the glenoid in young patients with glenohumeral arthritis |
author_sort |
Strauss, Eric J. |
journal |
Tu1421 Complications of Botulinum Toxin Injections for Treatment of Esophageal Motility Disorders |
journalStr |
Tu1421 Complications of Botulinum Toxin Injections for Treatment of Esophageal Motility Disorders |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology 500 - Science |
recordtype |
marc |
publishDateSort |
2014 |
contenttype_str_mv |
zzz |
container_start_page |
409 |
author_browse |
Strauss, Eric J. |
container_volume |
23 |
physical |
11 |
class |
610 610 DE-600 610 VZ 570 VZ BIODIV DE-30 fid 35.70 bkl 42.12 bkl 42.15 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Strauss, Eric J. |
doi_str_mv |
10.1016/j.jse.2013.06.001 |
dewey-full |
610 570 |
title_sort |
high failure rate of biologic resurfacing of the glenoid in young patients with glenohumeral arthritis |
title_auth |
The high failure rate of biologic resurfacing of the glenoid in young patients with glenohumeral arthritis |
abstract |
The current study evaluated the outcomes of biologic resurfacing of the glenoid using a lateral meniscus allograft or human acellular dermal tissue matrix at intermediate-term follow-up. |
abstractGer |
The current study evaluated the outcomes of biologic resurfacing of the glenoid using a lateral meniscus allograft or human acellular dermal tissue matrix at intermediate-term follow-up. |
abstract_unstemmed |
The current study evaluated the outcomes of biologic resurfacing of the glenoid using a lateral meniscus allograft or human acellular dermal tissue matrix at intermediate-term follow-up. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA GBV_ILN_26 GBV_ILN_40 GBV_ILN_65 |
container_issue |
3 |
title_short |
The high failure rate of biologic resurfacing of the glenoid in young patients with glenohumeral arthritis |
url |
https://doi.org/10.1016/j.jse.2013.06.001 |
remote_bool |
true |
author2 |
Verma, Nikhil N. Salata, Michael J. McGill, Kevin C. Klifto, Christopher Nicholson, Gregory P. Cole, Brian J. Romeo, Anthony A. |
author2Str |
Verma, Nikhil N. Salata, Michael J. McGill, Kevin C. Klifto, Christopher Nicholson, Gregory P. Cole, Brian J. Romeo, Anthony A. |
ppnlink |
ELV013436635 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth oth |
doi_str |
10.1016/j.jse.2013.06.001 |
up_date |
2024-07-06T18:29:13.817Z |
_version_ |
1803855387759214592 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV02831283X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623193151.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jse.2013.06.001</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014017000010.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV02831283X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1058-2746(13)00278-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.70</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.15</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Strauss, Eric J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The high failure rate of biologic resurfacing of the glenoid in young patients with glenohumeral arthritis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">11</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The current study evaluated the outcomes of biologic resurfacing of the glenoid using a lateral meniscus allograft or human acellular dermal tissue matrix at intermediate-term follow-up.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Treatment Study</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Level IV</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Case Series</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Verma, Nikhil N.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Salata, Michael J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McGill, Kevin C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Klifto, Christopher</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nicholson, Gregory P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cole, Brian J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Romeo, Anthony A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Mosby</subfield><subfield code="a">van Hoeij, Froukje B. ELSEVIER</subfield><subfield code="t">Tu1421 Complications of Botulinum Toxin Injections for Treatment of Esophageal Motility Disorders</subfield><subfield code="d">2015</subfield><subfield code="g">St. Louis, Mo</subfield><subfield code="w">(DE-627)ELV013436635</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:23</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:409-419</subfield><subfield code="g">extent:11</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jse.2013.06.001</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_26</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.70</subfield><subfield code="j">Biochemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.12</subfield><subfield code="j">Biophysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.15</subfield><subfield code="j">Zellbiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">23</subfield><subfield code="j">2014</subfield><subfield code="e">3</subfield><subfield code="h">409-419</subfield><subfield code="g">11</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.402916 |